Israeli Ministry of Health yesterday announced that it has authorized Enlivex Therapeutics Ltd [NASDAQ: ELNV] to proceed with phase II clinical trials for Allocetra, a
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
